Abstract
Immune-mediated necrotizing myopathy (IMNM) is a rare systemic idiopathic inflammatory myopathy associated with high functional disability. It is characterized by an acute/subacute condition of skeletal muscle weakness with elevated serum level of muscle enzymes. It tends to be refractory to conventional drug treatment (glucocorticoid and/or immunosuppressive drugs) and presents frequent …